Gene:
CHST3
carbohydrate (chondroitin 6) sulfotransferase 3

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this . To report a drug label with PGx, click here.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

This is a non-comprehensive list of genetic tests with pharmacogenetics relevance, typically submitted by the manufacturer and manually curated by PharmGKB. The information listed is provided for educational purposes only and does not constitute an endorsement of any listed test or manufacturer.

A more complete listing of genetic tests is found at the Genetic Testing Registry (GTR).

PGx Test Variants Assayed Related Drugs?

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page on the appropriate tab.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

Variant?
(138)
Alternate Names / Tag SNPs ? Drugs ? Alleles ?
(+ chr strand)
Function ? Amino Acid?
Translation
No VIP available CA VA
rs12418 *4785G>A, 24577478G>A, 53895G>A, 73773014G>A, CHST3:rs12418 A>G, NM_004273.3:c.*4785G>A
G > A
3' UTR
No VIP available CA VA
rs1871450 *3785G>A, 24576478G>A, 52895G>A, 73772014G>A, CHST3:rs1871450 A>G, NM_004273.3:c.*3785G>A
G > A
3' UTR
No VIP available CA VA
rs4148943 *1278C>T, 24573971C>T, 50388C>T, 73769507C>T, CHST3:rs4148943 C>T, NM_004273.3:c.*1278C>T
C > T
3' UTR
No VIP available CA VA
rs4148945 *1361C>T, 24574054C>T, 50471C>T, 73769590C>T, CHST3:rs4148945 C>T, NM_004273.3:c.*1361C>T
C > T
3' UTR
No VIP available CA VA
rs4148947 *1888T>C, 24574581T>C, 50998T>C, 73770117T>C, CHST3:rs4148947 C>T, NM_004273.3:c.*1888T>C
T > C
3' UTR
No VIP available CA VA
rs4148950 *3477G>A, 24576170G>A, 52587G>A, 73771706G>A, CHST3:rs4148950 A>G, NM_004273.3:c.*3477G>A
G > A
3' UTR
No VIP available CA VA
rs730720 *4533C>T, 24577226C>T, 53643C>T, 73772762C>T, CHST3:rs730720 A>G, NM_004273.3:c.*4533C>T
C > T
3' UTR
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP 138

Overview

Alternate Names:  None
Alternate Symbols:  C6ST; C6ST1
PharmGKB Accession Id: PA26503

Details

Cytogenetic Location: chr10 : q22.1 - q22.1
GP mRNA Boundary: chr10 : 73724120 - 73773322
GP Gene Boundary: chr10 : 73714120 - 73776322
Strand: plus
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.
No related genes are available

Curated Information ?

Evidence Drug
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
docetaxel
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
thalidomide

Curated Information ?

Evidence Disease
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Prostatic Neoplasms

Publications related to CHST3: 2

No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. The pharmacogenomics journal. 2010. Deeken J F, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. American journal of human genetics. 2008. Hermanns Pia, et al. PubMed

LinkOuts

Entrez Gene:
9469
OMIM:
143095
603799
608637
UCSC Genome Browser:
NM_004273
RefSeq RNA:
NM_004273
RefSeq Protein:
NP_004264
RefSeq DNA:
AC_000053
AC_000142
NC_000010
NG_012635
NT_030059
NW_001837987
NW_924796
UniProtKB:
CHST3_HUMAN (Q7LGC8)
Ensembl:
ENSG00000122863
GenAtlas:
CHST3
GeneCard:
CHST3
MutDB:
CHST3
ALFRED:
LO043183T
HuGE:
CHST3
Comparative Toxicogenomics Database:
9469
ModBase:
Q7LGC8
HumanCyc Gene:
HS04610
HGNC:
1971

Common Searches